Skip to main content
CBO estimates costs of implementing user fee reauthorization bill

The FDA would require appropriations worth $1.2 billion from 2018 to 2022 to implement changes in the Senate's user fee reauthorization bill, according to a cost estimate released by the Congressional Budget Office. Medical device program changes that would be implemented under the bill would add $243 million to the FDA's costs and require the agency to add at least 200 full-time-equivalent positions, the CBO said.

Full Story: